Open AccessRituximab in pemphigus vulgaris - Standard operating procedure
Author(s) -
Kidangazhiathmana Ajithkumar,
Sneha Johny,
Pinky Salim,
Neelakandhan Asokan
Publication year - 2021
Publication title -
journal of skin and sexually transmitted diseases
Language(s) - English
Resource type - Journals
eISSN - 2994-6026
pISSN - 2582-3175
DOI - 10.25259/jsstd_66_2020
Subject(s) - rituximab , pemphigus vulgaris , pemphigus , medicine , dermatology , immunology , antibody
Treatment of pemphigus poses a significant challenge in dermatology practice. Rituximab has recently been accepted as a first-line drug for pemphigus. This article tries to propose a standard operating procedure for the administration of rituximab.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom